Gapping up
In reaction to strong earnings/guidance: GALT +13.6% (aslo presents Phase 1 data at AASLD annual meeting advances GR-MD-02 into Phase 2 clinical development), CMCM +6.9%, CAK +5.9%, DF +5.8%, WWAV +4.3%, BID +4%, DDD +3.6%, RIG +2.6%, TOL +2.4%, XON +1.7%, NAT +1.3%, WSR +1.2%, LIOX +1.1%
M&A news: PT +6.6% (Daughter of Angola's President makes EUR 1.2 bln bid for Portugal Telecom SGPS SA, according to reports), SPWR +1.3% (acquires SolarBridge Technologies), T +0.7% (to acquire Mexico wireless provider Iusacell for $2.5 bln)
Select energy related names showing strength: SDRL +4.9%, JRJC +3.9%, STO +2.3%, ACI +1.4%, BTU +1.4%, TOT +1.2%
Other news: ROKA +24.3% (modestly rebounding from Friday's 64% drop), ACHN +6.9% ( reports 100% SVR12 in a Phase 2 combination study with ACH-3102), OIBR +4.2% (in connection with PT bid), GILD +3.1% (analyst notes poor MRK data released is net positive for GILD), BBRY +2.5% (considering China partnerships, meets with Lenovo (LNVGY), according to reports), SHPG +2% (still checking), NADL +2% (co and Rosneft agree to delay closing of planned transaction), OXGN +1.9% (presents Phase 2 data confirming that addition of Fosbretabulin to Bevacizumab significantly increases progression-free survival in recurrent ovarian cancer), BABA +1.9% (cont momentum higher post earnings)
Analyst comments: BMRN +2.5% (upgraded to Buy from Neutral at Goldman), FEYE +2% (added to Focus List at JP Morgan), AUQ +1.2% (upgraded to Buy from Hold at Canaccord Genuity), RDS.A71 +0.9% (upgraded to Outperform from Mkt Perform at Cowen)
In reaction to strong earnings/guidance: GALT +13.6% (aslo presents Phase 1 data at AASLD annual meeting advances GR-MD-02 into Phase 2 clinical development), CMCM +6.9%, CAK +5.9%, DF +5.8%, WWAV +4.3%, BID +4%, DDD +3.6%, RIG +2.6%, TOL +2.4%, XON +1.7%, NAT +1.3%, WSR +1.2%, LIOX +1.1%
M&A news: PT +6.6% (Daughter of Angola's President makes EUR 1.2 bln bid for Portugal Telecom SGPS SA, according to reports), SPWR +1.3% (acquires SolarBridge Technologies), T +0.7% (to acquire Mexico wireless provider Iusacell for $2.5 bln)
Select energy related names showing strength: SDRL +4.9%, JRJC +3.9%, STO +2.3%, ACI +1.4%, BTU +1.4%, TOT +1.2%
Other news: ROKA +24.3% (modestly rebounding from Friday's 64% drop), ACHN +6.9% ( reports 100% SVR12 in a Phase 2 combination study with ACH-3102), OIBR +4.2% (in connection with PT bid), GILD +3.1% (analyst notes poor MRK data released is net positive for GILD), BBRY +2.5% (considering China partnerships, meets with Lenovo (LNVGY), according to reports), SHPG +2% (still checking), NADL +2% (co and Rosneft agree to delay closing of planned transaction), OXGN +1.9% (presents Phase 2 data confirming that addition of Fosbretabulin to Bevacizumab significantly increases progression-free survival in recurrent ovarian cancer), BABA +1.9% (cont momentum higher post earnings)
Analyst comments: BMRN +2.5% (upgraded to Buy from Neutral at Goldman), FEYE +2% (added to Focus List at JP Morgan), AUQ +1.2% (upgraded to Buy from Hold at Canaccord Genuity), RDS.A71 +0.9% (upgraded to Outperform from Mkt Perform at Cowen)